The Advisory Board Co. (NASDAQ:ABCO) insider Cormac F. Miller sold 750 shares of the firm’s stock in a transaction that occurred on Wednesday, October 12th. The stock was sold at an average price of $43.15, for a total transaction of $32,362.50. Following the completion of the sale, the insider now owns 18,237 shares in the company, valued at approximately $786,926.55. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.
Shares of The Advisory Board Co. (NASDAQ:ABCO) traded down 0.02% during trading on Friday, hitting $43.47. 143,836 shares of the company’s stock were exchanged. The company has a 50-day moving average of $43.13 and a 200-day moving average of $37.24. The Advisory Board Co. has a 12-month low of $18.87 and a 12-month high of $54.83. The company’s market cap is $1.75 billion.
The Advisory Board (NASDAQ:ABCO) last released its quarterly earnings data on Wednesday, July 27th. The company reported $0.47 EPS for the quarter, beating the consensus estimate of $0.34 by $0.13. The business had revenue of $198.40 million for the quarter, compared to the consensus estimate of $196.49 million. The Advisory Board had a negative net margin of 10.21% and a positive return on equity of 11.59%. The business’s revenue for the quarter was up 7.4% on a year-over-year basis. During the same period in the prior year, the firm earned $0.40 EPS. On average, equities analysts expect that The Advisory Board Co. will post $1.86 earnings per share for the current fiscal year.
Several institutional investors have recently bought and sold shares of ABCO. BlackRock Inc. boosted its position in The Advisory Board by 16.2% in the second quarter. BlackRock Inc. now owns 3,263 shares of the company’s stock valued at $116,000 after buying an additional 455 shares in the last quarter. BNP Paribas Arbitrage SA boosted its position in The Advisory Board by 111.7% in the third quarter. BNP Paribas Arbitrage SA now owns 3,428 shares of the company’s stock valued at $153,000 after buying an additional 1,809 shares in the last quarter. Teacher Retirement System of Texas boosted its position in The Advisory Board by 13.8% in the second quarter. Teacher Retirement System of Texas now owns 5,856 shares of the company’s stock valued at $207,000 after buying an additional 708 shares in the last quarter. Atria Investments LLC purchased a new position in The Advisory Board during the third quarter valued at about $231,000. Finally, Princeton Alpha Management LP purchased a new position in The Advisory Board during the second quarter valued at about $236,000.
Several research analysts have weighed in on the stock. Barclays PLC increased their price target on shares of The Advisory Board from $44.00 to $50.00 and gave the stock an “overweight” rating in a research report on Friday, September 30th. Canaccord Genuity set a $50.00 price target on shares of The Advisory Board and gave the stock a “buy” rating in a research report on Wednesday, September 28th. Oppenheimer Holdings Inc. reiterated an “outperform” rating and issued a $49.00 price target (up from $45.00) on shares of The Advisory Board in a research report on Wednesday, September 28th. William Blair reiterated an “outperform” rating on shares of The Advisory Board in a research report on Tuesday, September 27th. Finally, Credit Suisse Group AG reiterated a “buy” rating and issued a $50.00 price target on shares of The Advisory Board in a research report on Friday, September 16th. Five analysts have rated the stock with a hold rating, eleven have issued a buy rating and one has issued a strong buy rating to the company’s stock. The stock presently has an average rating of “Buy” and an average target price of $44.07.
About The Advisory Board
The Advisory Board Company is a provider of software and solutions to the healthcare and higher education industries. The Company’s healthcare programs address a range of clinical and business issues, including physician alignment and engagement, network management and growth strategy, value-based care and population health, revenue cycle, clinical operations and supply chain.
Receive News & Ratings for The Advisory Board Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Advisory Board Co. and related companies with MarketBeat.com's FREE daily email newsletter.